Vila-Pueyo M, Goadsby PJ, Johnson KW, Holland PR, et al. Galcanezumab reduces trigeminal nociception and is effective in preclinical models of migraine and trigeminal autonomic cephalalgias. Headache 2025 Jul 21. doi: 10.1111/head.15006.
PMID: 40689463